BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 20932399)

  • 21. Oral HIV lesions and oral health behaviour of HIV-positive patients attending the Queen Elizabeth II Hospital, Maseru, Lesotho.
    Kamiru HN; Naidoo S
    SADJ; 2002 Dec; 57(11):479-82. PubMed ID: 12674869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress on study on oral lesions in patients with AIDS].
    Han Y; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 42(1):117-21. PubMed ID: 20140059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
    Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
    J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
    Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
    Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China].
    Wen Y; Li C; Pei J; Bai J; Yang X; Duan K
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):454-8. PubMed ID: 25351215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The differences between providing oral health care to HIV-infected children and HIV-infected adults: a general dentist's guide.
    Gonzales CB; Smith S; Galvan A; Mabry J
    Gen Dent; 2010; 58(5):424-32; quiz 733-4. PubMed ID: 20829168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa.
    Malele Kolisa Y; Yengopal V; Shumba K; Igumbor J
    PLoS One; 2019; 14(10):e0222568. PubMed ID: 31618211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.
    De Beaudrap P; Boullé C; Lewden C; Gabillard D; Nacro B; Diagbouga S; Fassinou P; Hien H; Laurent C; Msellati P;
    Pediatr Infect Dis J; 2013 Apr; 32(4):354-60. PubMed ID: 23099424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral lesions of the mouth in HIV-infected patients.
    Itin PH; Lautenschlager S
    Dermatology; 1997; 194(1):1-7. PubMed ID: 9031782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral manifestations related to immunosuppression degree in HIV-positive children.
    Santos LC; Castro GF; de Souza IP; Oliveira RH
    Braz Dent J; 2001; 12(2):135-8. PubMed ID: 11450684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (A3) HIV Phenotypes, oral lesions, and management of HIV-related disease.
    Blignaut E; Patton LL; Nittayananta W; Ramirez-Amador V; Ranganathan K; Chattopadhyay A
    Adv Dent Res; 2006 Apr; 19(1):122-9. PubMed ID: 16672562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral lesions associated with human immunodeficiency virus disease.
    Patton LL
    Dent Clin North Am; 2013 Oct; 57(4):673-98. PubMed ID: 24034072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral manifestations of human immunodeficiency virus-infected patients in Taiwan.
    Chiang CP; Chueh LH; Lin SK; Chen MY
    J Formos Med Assoc; 1998 Sep; 97(9):600-5. PubMed ID: 9795527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral manifestations associated with HIV infection: evaluation, assessment, and significance.
    Patel AS; Glick M
    Gen Dent; 2003; 51(2):153-6. PubMed ID: 15055688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.
    Glick M; Muzyka BC; Lurie D; Salkin LM
    Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):344-9. PubMed ID: 8015797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of cutaneous and oral diseases in HIV-infected men.
    Mirowski GW; Hilton JF; Greenspan D; Canchola AJ; MacPhail LA; Maurer T; Berger TG; Greenspan JS
    Oral Dis; 1998 Mar; 4(1):16-21. PubMed ID: 9655039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years.
    Greenwood I; Zakrzewska JM; Robinson PG
    Oral Dis; 2002 Mar; 8(2):90-4. PubMed ID: 11991309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.
    Campo J; Del Romero J; Castilla J; García S; Rodríguez C; Bascones A
    J Oral Pathol Med; 2002 Jan; 31(1):5-10. PubMed ID: 11896816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV infection and oral health care in South Africa.
    Rudolph MJ; Ogunbodede EO
    SADJ; 1999 Dec; 54(12):594-601. PubMed ID: 16892566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.